NO20003804D0 - FremgangsmÕte for fremstilling av absorberbare mikropartikler - Google Patents
FremgangsmÕte for fremstilling av absorberbare mikropartiklerInfo
- Publication number
- NO20003804D0 NO20003804D0 NO20003804A NO20003804A NO20003804D0 NO 20003804 D0 NO20003804 D0 NO 20003804D0 NO 20003804 A NO20003804 A NO 20003804A NO 20003804 A NO20003804 A NO 20003804A NO 20003804 D0 NO20003804 D0 NO 20003804D0
- Authority
- NO
- Norway
- Prior art keywords
- making absorbable
- microparticles
- absorbable microparticles
- making
- absorbable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE980054 | 1998-01-29 | ||
| PCT/IE1999/000007 WO1999038535A1 (en) | 1998-01-29 | 1999-01-25 | Process for making absorbable microparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003804D0 true NO20003804D0 (no) | 2000-07-25 |
| NO20003804L NO20003804L (no) | 2000-09-20 |
Family
ID=11041696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003804A NO20003804L (no) | 1998-01-29 | 2000-07-25 | FremgangsmÕte for fremstilling av absorberbare mikropartikler |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6555156B1 (no) |
| EP (1) | EP1051194B9 (no) |
| JP (1) | JP2002501907A (no) |
| CN (1) | CN1289255A (no) |
| AR (1) | AR014069A1 (no) |
| AT (1) | ATE240121T1 (no) |
| AU (1) | AU740493B2 (no) |
| CA (1) | CA2318513A1 (no) |
| DE (1) | DE69907870T2 (no) |
| DK (1) | DK1051194T3 (no) |
| ES (1) | ES2194437T3 (no) |
| HU (1) | HUP0102373A2 (no) |
| IL (1) | IL137349A0 (no) |
| NO (1) | NO20003804L (no) |
| PL (1) | PL342135A1 (no) |
| PT (1) | PT1051194E (no) |
| WO (1) | WO1999038535A1 (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413539B1 (en) * | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| IES990700A2 (en) * | 1999-08-18 | 2001-08-22 | Kinerton Ltd | Process to make a sustained release formulation |
| US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| US7229966B2 (en) | 2002-12-17 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| EA008829B1 (ru) | 2002-12-17 | 2007-08-31 | Нэстек Фармасьютикал Кампани Инк. | Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения |
| US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| BRPI0416042A (pt) * | 2003-11-13 | 2007-01-02 | Alza Corp | composição e aparelho para suprimento transdérmico |
| EP1703895A2 (en) * | 2004-01-13 | 2006-09-27 | Vasogenix Pharmaceuticals, Inc. | Controlled release cgrp delivery composition for cardiovascular and renal indications |
| JP2007517911A (ja) * | 2004-01-13 | 2007-07-05 | バソジェニックス ファーマシューティカルズ， インコーポレイテッド | 心臓血管の適応症および腎臓の適応症に対してｃｇｒｐを使用する方法 |
| US20090023643A1 (en) * | 2004-01-13 | 2009-01-22 | Vasogenix Pharmaceuticals, Inc. | Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same |
| US7578951B2 (en) * | 2004-01-27 | 2009-08-25 | Hewlett-Packard Development Company, L.P. | Method of making microcapsules utilizing a fluid ejector |
| WO2006044968A2 (en) | 2004-10-19 | 2006-04-27 | Achillion Pharmaceuticals, Inc. | Combination therapy for treating viral infections |
| FR2880272A1 (fr) * | 2005-01-04 | 2006-07-07 | Jean Marc Ruiz | Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication |
| EP2952522B1 (en) | 2007-01-31 | 2019-10-30 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| AU2008232709C1 (en) | 2007-03-28 | 2015-01-15 | President And Fellows Of Harvard College | Stitched polypeptides |
| CA2730760A1 (en) * | 2008-07-16 | 2010-01-21 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles containing bioactive peptides |
| US8968787B2 (en) * | 2010-05-24 | 2015-03-03 | Micro Powders, Inc. | Composition comprising biodegradable polymers for use in a cosmetic composition |
| KR20170058446A (ko) | 2010-08-13 | 2017-05-26 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| DE102011114864A1 (de) | 2011-10-05 | 2013-04-11 | Acino Ag | Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat |
| AR088392A1 (es) | 2011-10-18 | 2014-05-28 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos |
| CA2862038C (en) | 2012-02-15 | 2021-05-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| BR112015009470A2 (pt) | 2012-11-01 | 2019-12-17 | Aileron Therapeutics Inc | aminoácidos dissubstituídos e seus métodos de preparação e uso |
| WO2016049359A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CA3004363A1 (en) | 2015-11-06 | 2017-05-11 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US5385738A (en) | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| US5011692A (en) | 1985-12-28 | 1991-04-30 | Sumitomo Pharmaceuticals Company, Limited | Sustained pulsewise release pharmaceutical preparation |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5077049A (en) | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| CA2046830C (en) | 1990-07-19 | 1999-12-14 | Patrick P. Deluca | Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer |
| AU653771B2 (en) * | 1991-01-03 | 1994-10-13 | Alkermes Controlled Therapeutics, Inc. | Stabilization of proteins by cationic biopolymers |
| US5366756A (en) | 1992-06-15 | 1994-11-22 | United States Surgical Corporation | Method for treating bioabsorbable implant material |
| US5672659A (en) | 1993-01-06 | 1997-09-30 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| EP0712421A1 (en) * | 1993-07-23 | 1996-05-22 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5612052A (en) | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US5665702A (en) | 1995-06-06 | 1997-09-09 | Biomeasure Incorporated | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| US5874029A (en) * | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
| US6270700B1 (en) * | 1998-07-23 | 2001-08-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Encapsulation of water soluble peptides |
-
1999
- 1999-01-25 AR ARP990100287A patent/AR014069A1/es unknown
- 1999-01-25 IL IL13734999A patent/IL137349A0/xx unknown
- 1999-01-25 US US09/601,074 patent/US6555156B1/en not_active Expired - Fee Related
- 1999-01-25 PL PL99342135A patent/PL342135A1/xx unknown
- 1999-01-25 DE DE69907870T patent/DE69907870T2/de not_active Expired - Lifetime
- 1999-01-25 JP JP2000529267A patent/JP2002501907A/ja active Pending
- 1999-01-25 ES ES99902793T patent/ES2194437T3/es not_active Expired - Lifetime
- 1999-01-25 PT PT99902793T patent/PT1051194E/pt unknown
- 1999-01-25 HU HU0102373A patent/HUP0102373A2/hu unknown
- 1999-01-25 AT AT99902793T patent/ATE240121T1/de not_active IP Right Cessation
- 1999-01-25 EP EP99902793A patent/EP1051194B9/en not_active Expired - Lifetime
- 1999-01-25 CN CN99802448A patent/CN1289255A/zh active Pending
- 1999-01-25 WO PCT/IE1999/000007 patent/WO1999038535A1/en not_active Ceased
- 1999-01-25 AU AU22966/99A patent/AU740493B2/en not_active Ceased
- 1999-01-25 CA CA002318513A patent/CA2318513A1/en not_active Abandoned
- 1999-01-25 DK DK99902793T patent/DK1051194T3/da active
-
2000
- 2000-07-25 NO NO20003804A patent/NO20003804L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL137349A0 (en) | 2001-07-24 |
| AU740493B2 (en) | 2001-11-08 |
| WO1999038535A1 (en) | 1999-08-05 |
| DE69907870D1 (de) | 2003-06-18 |
| HUP0102373A2 (hu) | 2001-10-28 |
| AU2296699A (en) | 1999-08-16 |
| ATE240121T1 (de) | 2003-05-15 |
| PL342135A1 (en) | 2001-05-21 |
| JP2002501907A (ja) | 2002-01-22 |
| EP1051194A1 (en) | 2000-11-15 |
| DK1051194T3 (da) | 2003-09-01 |
| CA2318513A1 (en) | 1999-08-05 |
| EP1051194B1 (en) | 2003-05-14 |
| AR014069A1 (es) | 2001-01-31 |
| PT1051194E (pt) | 2003-09-30 |
| EP1051194B9 (en) | 2003-11-05 |
| ES2194437T3 (es) | 2003-11-16 |
| DE69907870T2 (de) | 2004-03-04 |
| CN1289255A (zh) | 2001-03-28 |
| US6555156B1 (en) | 2003-04-29 |
| NO20003804L (no) | 2000-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003804D0 (no) | FremgangsmÕte for fremstilling av absorberbare mikropartikler | |
| DK1053020T3 (da) | Absorberbare mikropartikler | |
| ID26007A (id) | Proses karbonilasi | |
| ID27308A (id) | Proses aksidasi | |
| ID23316A (id) | Proses karbonilasi | |
| ID28724A (id) | Proses untuk memproduksi sikloalkanon | |
| DE19982499T1 (de) | Verbessertes Formverfahren | |
| ID29177A (id) | Proses pembuatan urea | |
| NO995287L (no) | Forbedret fremgangsmõte for fremstilling av sjokolade | |
| ID26016A (id) | Proses untuk menghasilkan hinokitiol | |
| ATE248019T1 (de) | Verbessertes extrusionsverfahren | |
| ID23155A (id) | Proses pembuatan eprosartan | |
| ID27412A (id) | Proses pembuatan urea | |
| ID28625A (id) | Proses untuk modifikasi pektin secara enzimatik | |
| NO992797D0 (no) | FremgangsmÕte for fremstilling av et eter-karboksylatsalt | |
| ID23181A (id) | Proses pembuatan eprosartan | |
| ID27452A (id) | Proses untuk membuat urea 1,3-tersubstitusi-4-oksosiklik | |
| ID26938A (id) | Proses pembuatan tetrapeptida | |
| ID26021A (id) | Proses untuk menyiapan 1h-indole-3-glioksamida disubstitusi-4 1h-indole-glioksamida disubstitusi-4 | |
| ID27404A (id) | Proses asilasi | |
| ID27316A (id) | Proses untuk membuat urea 1,3-terdisubstitusi-4-oksosiklik | |
| FI982822L (fi) | Lyhyen kierron prosessijärjestely | |
| DE69811850D1 (de) | Extrusionsverfahren | |
| NO20013175L (no) | Fremgangsmåte for fremstilling av supraledende bånd | |
| JP2001514250A5 (ja) | カプロラクタムの製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |